2m 2m 2m 2m 2m 2m 2m
Abbott Laborator (ABT)
NYSE
$92.29+$0.18 (+0.20%)
Price as of Jul 13, 2026 7:57 PM EDT- $164.4BMarket Cap
- -27.40%1-Year Change
- Medical DevicesIndustry
Abbott Laborator (ABT)
$92.29+$0.18 (+0.20%)
ABT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $92.11 | ||
Change | -$0.47 (-0.50%) | ||
Open | $93.95 | ||
High | $94.10 | ||
Low | $91.64 | ||
Previous Close | $94.40 | ||
Volume | 6,913,070 | ||
30-Day Average Volume | 13,628,351 | ||
1-Week Change | -1.54% | ||
1-Month Change | 5.34% | ||
1-Year Change | -27.40% | ||
3-Year Change | -6.79% | ||
5-Year Change | -13.83% | ||
Fundamentals | |||
Shares Outstanding | 1.7B | ||
Total Assets | $110.4B | ||
Market Cap | $164.4B | ||
Enterprise Value | $191.7B | ||
Period: QTR TTM FY | |||
Revenue | $11.2B | ||
Net Income | $1.1B | ||
Free Cash Flow | $916.0M | ||
EBIT | $1.5B | ||
EBITDA | $1.9B | ||
Net Working Capital | $7.1B | ||
EPS | $0.61 | ||
Enterprise Value/EBITDA | 99 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 3 | ||
P/E | 154 | ||
PEG | -4 | ||
Price/Free Cash Flow | 179 | ||
Price/Operating Cash Flow | 124 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.68% | ||
Trailing Annual Dividend Yield | 2.60% | ||
Ex-Dividend Date | 07/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield